Celgene Study Site

Calgary, Alberta

We've found

1 trials

at this facility

Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma

Status: Enrolling
Updated: 4/24/2017

from

Calgary,

Use our guide to learn which trials are right for you!